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ABSTRACT 
Objective: To assess consensus in the interpretation of cardiotocographs (CTGs) and non-stress 
tests (NSTs) between different grades of obstetric clinical staff by comparing assessment of 
traces by non-systematic eyeballing with assessment of traces using a tabular approach suggested 
by the National Institute of Health and Clinical Excellence (NICE) guidelines for interpretation 
of CTGs and NSTs, and to identify components ofNSTs and CTGs where medical personnel 
experience difficulty with interpretation. 
Design: Prospective observational study. 
Setting: Maternity units of the tertiary care hospitals for the teaching and training of the 
Witwatersrand University postgraduates, interns and midwives. 
Participants: Midwives, advanced midwives, interns, medical officers, registrars and specialists 
working in the above-mentioned maternity units. 
Method: Participants were recruited at the time of formal gatherings and departmental meetings 
in the various institutions. Each participant was given five traces that were a combination of 
NSTs and CTGs to interpret and assess in a non-systematic way using three categories: baby 
well; baby requires further surveillance; and baby needs immediate delivery. The same 
participants were then given the same set of traces in a different sequence for interpreting in a 
systematic way using the tabular approach from the NICE guidelines on electronic fetal 
monitoring with a scoring modification. 
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Main outcome measure: Differences in interpretation of CTGs by different grades of staff, and 
degree of certainty between study participants in the different assessment systems. 
Results: Twenty seven specialists, 25 registrars, 21 medical officers, 10 interns and 15 midwives 
participated. There were varying interpretations by individuals in both the non-systematic 
assessment and the systematic assessment using the NICE tabular application, with best 
agreement in Trace 3 (77% and 84% respectively). In the non-systematic assessment, there was a 
statistically significant difference in the assessment of traces 1, 2 and 4 between the different 
grades ofstaff(P-values<0.01, 0.03 and <0.01 respectively). There was no statistically 
significant difference when the traces were assessed using the NICE guidelines tabular 
application (P-values; Trace1 >0.99, Trace2=0.27, Trace 3 = 0.76, Trace 4 = 0.15 and Trace5 = 
0.35).Certainty of the evaluation by the participants was determined if75% or more of the 
participants agreed on a classification. Using the NICE guidelines, there was uncertainty (failure 
to agree on classification by 75% or more of the participants) with baseline variability, 
accelerations, decelerations and overall assessment of the CTG in most of the traces. 
Conclusion: There is no uniformity in the assessment of traces by midwives, interns, medical 
officers, registrars and specialists. Some uniformity in the interpretation of traces and reduction 
in inter-observer variation is attained by the use of the NICE guidelines tabular application. 
However, baseline variability, accelerations, and decelerations remain a problem in the 
interpretation ofNSTs and CTGs using the NICE guidelines. 
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1. INTRODUCTION 
The ability to diagnose fetal life through auscultation ofthe fetal heart marked the 
beginning of fetal monitoring. An interest as to how to recognize changes in fetal heart 
rate in order to prevent perinatal mortality mounted. A considerable advancement in the 
techniques of auscultation led to the development of electronic fetal monitoring. 1 Over the 
years the techniques of electronic fetal monitoring improved but the interpretation of fetal heart 
rate (FHR) patterns has not been optimized and hence the tool for determining fetal well-being 
has only been as good as the interpreter. The challenge is no longer to perfect the test but to unify 
and hence improve interpretation. 
1.1 Electronic fetal heart rate monitoring (EFl\'1) 
Electronic fetal monitoring (EFM) employs the use of ultrasound to evaluate the fetal heart rate 
in-utero and hence fetal brain function. There are two categories of monitoring: 
1) Non-Stress test (NST) measures the FHR by means of an ultrasonic sensor in the absence 
of uterine contractions where uterine contractions are perceived as the stress. 
2) Cardiotocography (CTG) measures the FHR by means of an ultrasonic sensor, in relation 
to uterine contractions which are monitored using a tocodynamometer. 
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Interpretation of an NST relies on the assessment of the following parameters: 
1) Baseline FHR 
2) Baseline FHR variability 
3) The presence of accelerations 
4) Interpretation of decelerations 
The interpretation of a CTG includes assessment of the above-mentioned components of an NST 
and in addition the assessment of uterine activity represented on the tocograph. 
Effective EFM requires a correctly performed test, adequate interpretation ofthe results, and an 
appropriate response based on the interpretation. 1• 2 
1.2 The use of electronic fetal monitoring 
Electronic fetal monitoring was intended to detect fetal hypoxia before the development of fetal 
acidosis and ensuing perinatal mortality, and thus improve the birth outcome and prevent 
cerebral palsy. 3• 4' 5 This technique became widely used from the 1960s, and is a widely accepted 
method for fetal surveillance in pregnancy and during labour.1• 6•7 
1.3 The efficacy of electronic fetal monitoring 
Many studies have been conducted to assess the efficacy ofEFM. In 2001 a Cochrane meta-
analysis of EFM showed only a minor beneficial effect on the incidence of neonatal seizures 
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(RR, 0.5; 95% CI, 0.31-0.8), no effect on the incidence of cerebral palsy (RR, 1. 74; 95% CI, 0.9 
-3.11) or perinatal death (RR, 0.85; 95% CI, 0.59-1.23), but an increase in operative vaginal 
delivery (RR, 1.16; 95% CI, 1.0 -1.32) and caesarian section (RR, 1.66; 95% CI,1.3-2.13).8 The 
negative predictive value ofEFM ranges from 93%- 99% .2 The positive predictive value is 
much lower and ranges between 8% and 26%.2 This indicates a high false positive and a low 
false negative rate for fetal compromise. 
The 4th Confidential Enquiry into Stillbirths and Deaths in Infancy in the United Kingdom 
highlighted problems related to the use and interpretation of continuous tocographic (CTG) 
traces where CTG misinterpretations as well as inappropriate action in the presence of abnormal 
fetal heart rate changes are the most common alleged negligences.9• 10• 11 
1.4 The interpretation of electronic fetal heart rate components 
In practice, a CTG trace is usually interpreted as a whole based on the contribution of the four 
features described earlier. Depending on the system used for CTG interpretation, the FHR 
components are defmed and further categorized. After categorizing the individual components, 
the CTG trace is classified. A complete clinical understanding of EFM is necessary for one to 
appreciate changes in the above-mentioned characteristics. 
Variations in the interpretation of FHR components and patterns between observers, even 
amongst experts, have led to extensive research on the topic. Most studies have demonstrated 
that identification of FHR baseline among observers was fair to good, whereas interpretation or 
'd 'fi . f 1 . d d 1 . 1 2 12 13 1 entl 1cat10n o acce erat10ns an ece erat10ns vary . ' ' ' 
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Baseline variability has been found to be the most difficult to interpret visually.14 Several studies 
revealed no parity in the classification of FHR variability. 1•5•12•15 It has been noted that clinicians 
have a tendency to over-report abnormalities especially with reduced variability and variable 
decelerations. 14 
In 1978, Trimbos et al. were the first to investigate inter- and intra-observer agreement in the 
interpretation of CTG tracings. 13 Concerns were raised regarding the reliability of visual 
interpretation of CTG tracings soon after EFM was introduced. Five observers were given 100 
CTGs to interpret independently on two occasions.13 They found the highest level of agreement 
among observers in the assessment of baseline FHR, followed by decelerations and the lowest 
level of agreement in the recognition of accelerations. 13 Ninety seven percent of traces were 
scored the same by all five observers in terms of baseline FHR description, whereas 65% in the 
detection of decelerations and only 34% in the recognition of accelerations. 13 
In 1982, Lotgering et al. found that the overall intra-observer agreement was high (k = 0.7- 0.8) 
whereas the inter-observer agreement was low (k = 0.09 - 0.69) for all variables assessed. 15 The 
highest level of agreement was in the assessment of baseline fetal heart rate for both intra-
observers (k = 0.83 - 0.89) and inter-observers (k = 0.53 - 0.69). Agreement was lowest in the 
assessment of baseline variability for both intra-observers (k = 0.12- 0.46) and inter-observers 
(k = 0.09- 0.32). 15 
Nielsen et al. also noted considerable intra- and inter-observer variability in 1987 when he gave 
four obstetricians 50 tracings on two occasions to identify pathological tracings. 5 Twenty one 
percent of the traces were interpreted differently at the second observation. Only 22% of the 
traces were assessed the same by all four obstetricians. 
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In 1993, Donker et al. asked 21 experienced obstetricians to describe and classify13 CTG 
tracings.2 They were then given clinical information on each patient and were asked to assess the 
fetal condition and to propose obstetric management. Results showed fair agreement among 
observers on the classification ofbaseline FHR, accelerations and decelerations (overall k = 0.48, 
range 0.04- 0.53). There was poor agreement for baseline variability (k = 0.16, range 0.01-
0.21) and for the type of deceleration. The overall CTG interpretation, clinical assessment and 
obstetric management also showed poor agreement among the observers. It was concluded that 
there is still use of ambiguous terminology and definitions in the assessment of fetal heart rate 
tracings. Standardization of terminology, definitions and criteria for FHR analysis were 
suggested as one of the solutions. The use of computerized analysis was thought to be another 
helpful tool as it would assess fetal heart rate patterns consistently. 2 
In 1996, a comparison between two experienced obstetricians, two non-experienced 
obstetricians, and a computer system on reproducibility ofCTG readings was done by Todros et 
al. 16 They observed that the overall reproducibility among the observers was fair to good (k = 
0.05 - 0.67) for most variables. There was poor agreement (k = 0.10- 0.48) between the 
observers and computer readings for baseline FHR. The agreement was fair to good for baseline 
variability (k = 0.16- 0.74), acceleration (k = 0.37- 0.64) and decelerations (k = 0.41- 0.54) 
between the observers and the computer readings. The authors concluded that the use of a 
computer system should overcome the problem of intra- and inter-observer variability. 16 
In 1997, Bemades et al. evaluated inter-observer agreement in the classification ofCTGs by 
giving three experienced obstetricians 33 CTGs to interpret using the FIGO guidelines and 
relevant clinical information. 12 Agreement was fair to good in the assessment of baseline, 
accelerations and uterine contractions. There was poor agreement in the detection of 
11 
decelerations. Agreement in the assessment of baseline variability was good if it was considered 
normal, but poor if considered abnormal. It was observed that CTG reproducibility is still poor 
even when performed by experienced clinicians with consensual guidelines and access to clinical 
information. It was also noted that reproducibility was good in detection of more gross and stable 
CTG events but poor in detection of subtle alterations. 12 These fmdings were attributed to 
ambiguous defmitions, interdependence of defmitions, difficulty in eyeball evaluation of subtle 
CTG alterations and difficulty in systematic and disciplined assessment of CTGs by busy 
clinicians. It was suggested that guidelines for EFM should be revised and more precise 
definitions of CTG events included. A more disciplined method of CTG analysis by the 
clinicians and the use of computerized analysis were also suggested.12 
The National Institute of Child Health and Human Development in the United States conducted a 
Research Planning Workshop in 1997 on electronic fetal heart rate monitoringYThe purpose of 
the workshop was to propose standardized and unambiguous defmitions for fetal heart rate 
tracings. Recommendations for the interpretation of fetal heart rate patterns were laid down. 17 
In the assessment of midwives in 2005 Devane et al. asked 28 midwives to interpret three 
intrapartum CTGs independently on two separate occasions.5 The midwives assessed the 
individual heart rate components and classified the tracings into normal, suspicious and 
pathological using the FIGO and Family Health International guidelines. They found that the 
overall intra-observer agreement in CTG interpretation was fair to good to excellent (k = 0.48 -
0.92), similar to Lotgering et al. fmdings in 1982.15 The overall inter-observer agreement in the 
interpretation ofCTG tracings was m the upper limit of fair to good category (k = 0.65- 0.74). 
Inconsistent with the literature, the agreement was highest in the classification of decelerations (k 
= 0.79).5 Agreement was the lowest in the assessment ofbaseline variability (k = 0.5), a fmding 
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which is in keeping with the literature. The agreement was highest in suspicious tracings (k = 
0.77) and lowest in normal tracings (k = 0.54), a finding which is in contrast with the literature. 
Devane et al. attributed the small number of tracings used in the study as the possible reasons for 
the conflicting results. 5 
1.5 Assessment of electronic fetal heart rate patterns 
In one study it was found that errors of interpretation are reduced if FHR traces are categorized 
as a whole, with reference to individual features. 18' 19 The four features of the fetal heart ~ate must 
be described (baseline FHR, baseline variability, accelerations and decelerations). Each feature is 
then categorized into normal, suspicious or abnormal. Based on the contribution of all the 
features, the whole CTG is classified. The interpretation of CTGs was more consistent in normal 
traces than seen with suspicious or pathological traces. 18• 19' 20 In 1999, Ayres-de-Campos et al. 
used the same setting as Bemades et al. Observers classified the CTGs as normal, suspicious, or 
pathological according to the FIGO guidelines.20 They were also requested to decide on one of 
the clinical management options: no action, close monitoring or immediate intervention. The 
overall agreement in the classification of FHR tracings was in the lower limit of fair to good 
category (k = 0.48; 95% CI 0.34-0.62). There was reasonable agreement for normal tracings (Pa 
= 0.62; 95% CI 0.51-0.73) and poor agreement for suspicious (Pa = 0.42; 95% CI 0.34-0.50) and 
pathological tracings (Pa = 0.25; 95% CI 0.14-0.36). Agreement was significantly better for no 
action (Pa = 0.79; 95% CI 0.68-0.89) than for close monitoring (Pa = 0.14; 95% CI 0.02-0.43) or 
immediate intervention (Pa = 0.38; 95% CI 0.21-0.56). It was noted that disagreement occurred 
mainly when situations diverged from normal.20 
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Similar to previous studies were the findings by Blix et al. in 2003. They evaluated inter-
observer variation in the assessment of 845 labour admission CTGs by midwives and 
obstetricians in the clinical setting and two experts in the non-clinical setting. The traces were 
assessed according to the Ingemarsson and Ingemarsson classification as reactive, equivocal or 
ominous (Table 1 ). Proportions of agreement were high for reactive traces and low for equivocal 
and ominous traces. 18 
Based on the above findings, it seems that inter-observer and intra-observer consistency of 
interpretation remains poor even with the introduction of specific guidelines for interpreting fetal 
heart rate traces. 6 
Table 1 Classification of fetal heart rate patterns according to Ingemarsson et al. 18 
Reactive 
Equivocal 
Ominous 
Two accelerations (more than 15 beats, more than 15 
seconds) in 10-20 minutes. Traces without 
accelerations but normal baseline and variability. 
Absence of accelerations with reduced variability or 
silent pattern, but normal frequency. Uncomplicated 
(normal variability) tachycardia or bradycardia. 
Uncomplicated variable decelerations. 
Silent pattern and tachycardia or bradycardia. Late 
decelerations, complicated variable decelerations. Heart 
frequency less than 100 beats per minute or prolonged 
deceleration. 
1.6 Guidelines for the interpretation of NSTs and CTGs 
Several organizations have produced fetal monitoring guidelines with partly assimilated 
concepts, some contradictory aspects, some with excessively complex rules. 1 The three-class 
classification system approach that classifies CTGs into one of three categories (normal, 
abnormal or indeterminate) has now been accepted by all because of its simplicity?1 
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1.6.1The International Federation of Gynecology and Obstetrics (FIGO) guidelines 
The first guidelines for the use of fetal monitoring were produced in a workshop that was 
organized by the International Federation of Gynecology and Obstetrics (FIGO) Subcommittee 
on Standards in Perinatal Medicine in 1985.22 The aim ofthese guidelines was to assist in the 
correct use of electronic fetal heart rate monitoring. A consensus was reached on several aspects 
of fetal heart rate monitoring including the method, terminology, indications, technique and 
interpretation. The FIGO guidelines apply separate classification criteria for antepartum and 
intrapartum fetal heart rate pattems.22 The guidelines are shown in Tables 2 and 3. 
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Table 2 Definitions of FHR features according to the FIGO guidelines22 
TERM 
Baseline fetal heart rate 
Baseline variability 
Accelerations 
Decelerations 
Sinusoidal pattern 
DEFINITION 
The mean level of the fetal heart rate when this is 
stable, accelerations and decelerations being absent. 
It is determined over a time period of 5 or 10 min 
and expressed in beats/min (bpm). 
Oscillations of fetal heart rate around its mean 
level (long term variability). 
It is usually only quantitated by description of the 
amplitude of the oscillations around the baseline heart 
rate. Under physiological conditions the fetal beat-to-
beat intervals are constantly subject to small changes 
called short term variability. These cannot be reliably 
interpreted by the naked eye using the standard 
equipment. 
Transient increase in heart rate of 15 beats/min or more 
and lasting 15 seconds or more. 
Transient episodes of slowing of fetal heart rate below 
the baseline level of more than 15 beats/min and 
lasting 10 seconds or more. 
Regular cyclic changes in the fetal heart rate baseline, 
such as the sine wave. The characteristics of the 
pattern being: the frequency is less than 6 cycles/min, 
the amplitude is at least 10 beats/min and the duration 
should be 20 min or longer. 
*FIGO guidelines do not provide a definition of early, variable or late decelerations. 
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Table 3 Classification of fetal heart rate patterns according to the FIGO guidelines.22 
ANTEPARTUM 
Normal 
Baseline heart rate between 11 0 and 
150bpm 
Amplitude of heart rate variability 
between 5 and 25 bpm 
Absence of decelerations except for 
sporadic, mild decelerations of very short 
duration 
Presence of two or more accelerations 
during a 1 0-minute period 
Suspicious (if any of the following signs 
are present) 
Baseline heart rate between 150 and 
170 bpm or between 100 and 110 bpm 
Amplitude of variability between 5 and 
1 0 bpm for more than 40minutes 
Increased variability above 25 bpm 
Absence of accelerations for more than 
40 minutes 
Sporadic decelerations of any type unless 
severe 
Pathological (when any of the following signs 
are present) 
Baseline heart rate below 100 or above 
170 bpm 
Persistence of heart rate variability of less 
than 5 bpm for more than 40 minutes 
minutes 
Periodically recurring and repeated 
decelerations of any type 
Sporadic and non-recurrent decelerations 
of the following types: severe variable, 
prolonged, late 
A sinusoidal pattern 
INTRAPARTUM 
Normal 
- Baseline heart rate between 110 and150bpm 
- Amplitudeof heart rate variability between 
5 and 25 bpm 
Suspicious (if any of the following 
are present) 
- Baseline heart rate between 150 and 
170 or between 100 and 110 bpm 
- Amplitude of variability between 5 and 
10 bpm for more than 40minutes 
- Increased variability above 25 bpm 
-Variable decelerations 
Pathological 
-Baseline heart rate below 100 or above 
170bpm 
- Persistence of heart rate variability of 
less than 5 bpm for more than 40 
- Severe variable decelerations or severe 
repetitive early decelerations 
- Prolonged decelerations 
- Late decelerations: the ominous trace 
is a steady baseline without baseline 
variability and with small 
decelerations after each contraction 
- A sinusoidal pattern 
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1.6.2 The National Institute of Child Health and Human Development (NICHHD)/ 
American College of Obstetricians and Gynecologists (ACOG) guidelines 
The National Institute of Child Health and Human Development Research Planning Workshop 
held in 1997 proposed standardized definitions for fetal heart rate patterns which were then 
reviewed and pattern interpretation updated in 2008. The 2008 workshop was conducted in 
partnership with the American College of Obstetricians and Gynecologists (ACOG) and the 
Society of Maternal Fetal Medicine. The NICHHD/ACOG guidelines apply to intrapartum 
patterns, but can also apply to antepartum patterns.19 The guidelines are shown in Tables 4 and 5. 
Table 4 Definiti~ns of fetal heart rate features according to NICHHD/ ACOG19 
Baseline 
Baseline variability 
Acceleration 
The mean FHR rounded to increments of 5 beats per minute 
(bpm) during a 10 minute segment, excluding: 
-periodic or episodic changes 
- periods of marked FHR variability 
- segments of baseline that differ by more than 25 bpm 
The baseline must be for a minimum of 2 mins in any 1 0 -
minute segment, or the baseline for that time period is 
indeterminate. In this case one may refer to the prior 10-
minute window for determination of baseline. 
-Normal FHR baseline: 110-160 bpm 
-Tachycardia: FHR baseline >160 bpm 
-Bradycardia: FHR baseline < 110 bpm 
Fluctuations in the baseline FHR that are irregular in 
amplitude and frequency. 
Variability is visually quantitated as the amplitude of peak-
to-trough in bpm. 
- absent - amplitude range undetectable 
- minimal- amplitude range detectable but 5 bpm or fewer 
-moderate (normal)- amplitude range 6-25bpm 
- marked- amplitude range greater than 25 bpm 
A visually apparent abrupt increase (onset to peak in less 
than 30 seconds) in the FHR. 
At ~32weeks of gestation, an acceleration has a peak of 
~15 bpm above baseline, with duration of~l5seconds but 
< 2 minutes from onset to return. 
Before 32 weeks of gestation, an acceleration has a peak of 
~10 bpm above baseline, with a duration of~ 10 seconds 
but< 2 minutes from onset to return. 
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Early deceleration 
Late deceleration 
Variable deceleration 
Prolonged deceleration 
Sinusoidal pattern 
Prolonged acceleration lasts ::: 2 minutes but < 10 minutes. 
If an acceleration last ::: 10 minutes, it is a baseline change. 
Visually apparent usually symmetrical gradual decrease and 
and return of the FHR associated with a uterine contraction. 
A gradual FHR decrease is defined as from the onset to 
the FHR nadir of:::30 seconds. 
The decrease from the FHR is calculated from the onset to 
the nadir of the deceleration. 
The nadir of the deceleration occurs at the same time as the 
peak of the contraction. 
In most cases the onset, nadir and recovery of the 
deceleration are coincident with the beginning, peak 
and ending of the contraction, respectively. 
Visually apparent usually symmetrical gradual decrease and 
and return of FHR associated with a uterine contraction. 
A gradual FHR decrease is defined as from the onset to 
the FHR nadir of:::30 seconds. 
The decrease from the FHR is calculated from the onset to 
nadir of the deceleration. 
The deceleration is delayed in timing, with the nadir of the 
deceleration occurring after the peak of the contraction. 
In most cases, the onset, nadir and recovery of the 
deceleration occur after the beginning, peak, or ending of 
the contraction, respectively. 
Visually apparent abrupt decrease in FHR. 
An abrupt FHR decrease is defined as from the onset of the 
deceleration to the beginning of FHR nadir of< 30 
seconds 
The decrease from the FHR is calculated from the onset to 
nadir of the deceleration. 
The decrease in FHR is::: 15bpm lasting::: 15 seconds and 
< 2 minutes in duration. 
When variable decelerations are associated with uterine 
contractions, their onset, depth, and duration commonly 
vary with successive uterine contractions. 
Visually apparent decrease in FHR below the baseline. 
Decrease in FHR from the baseline that is ::: 15bpm lasting 
::: 2 minutes but < 10 minutes in duration. 
If a deceleration lasts ::: 10 minutes, it is a baseline change. 
Visually apparent, smooth, sine wave-like undulating 
pattern in FHR baseline with a cycle frequency of 3-5 per 
minute which persists for 20 minutes or more. 
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Table 5 Classification of fetal heart rate pattern according to NICCHD/ ACOG guidelines, 
2008.23 
(Reproduced from Reviews in Obstetrics and Gynecology)23 
Category I 
Normal tracings, which are strongly predictive of normal fetal acid-base status at the time of observation and can be 
followed in a routine manner without any specific action required, include all of the following: 
• Baseline rate: 110-160 beats/min 
• Moderate variability 
• Absence of any late or variable decelerations 
• Early decelerations may or may not be present 
• Accelerations may or may not be present 
Category II 
Indeterminate tracings, although not predictive of abnormal fetal acid-base status, cannot be classified as Category I 
or ill and thus require evaluation and continued surveillance and reevaluation. These tracings are not infrequently 
encountered in clinical care, and include any of the following: 
• Baseline rate 
- Tachycardia 
- Bradycardia not accompanied by absent baseline variability 
• Baseline FHR variability 
- Minimal baseline variability 
- Absent baseline variability not accompanied by recurrent decelerations 
- Marked baseline variability 
• Absence of induced accelerations after fetal stimulation (e.g. scalp stimulation, vibroacoustic stimulation, direct 
fetal scalp sampling, transabdominal halogen light) 
• Periodic or episodic decelerations 
- Recurrent variable decelerations accompanied by minimal or moderate baseline variability 
-Prolonged deceleration more or equal to 2 min but less than 10 min 
- Recurrent late decelerations with moderate baseline variability 
-Variable decelerations with other characteristics, such as slow return to baseline, "overshoots," or "shoulders" 
Category III 
Abnormal tracings, which are predictive of abnormal fetal acid-base status at the time of observation, require prompt 
evaluation and initiation of expeditious attempts to resolve the abnormal FHR pattern, such as provision of maternal 
oxygen, change in maternal position, discontinuation of labor stimulation, treatment of maternal hypotension, or 
additional efforts. These tracings include either: 
• Absent baseline FHR variability along with any of the following: 
- Recurrent late decelerations 
-Recurrent variable decelerations 
- Bradycardia 
• Sinusoidal pattern 
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1.6.3 The NICE/Royal College of Obstetricians and Gynaecologists (RCOG) guidelines 
The most recent guidelines on fetal monitoring were developed by the National Institute of 
Health and Clinical Excellence (NICE) and produced by the Royal College of Obstetricians and 
Gynecologists (RCOG) in 2001. These will be elaborated in detail below as this study is on the 
NICE guidelines. The NICE guidelines were chosen for evaluation for these reasons: the fetal 
heart rate features are described (as with the other guidelines), the FHR features are further 
classified into reassuring, non-reassuring and abnormal (not done by the other two guidelines, 
FIGO and NICHHD/ACOG). This makes the overall assessment of the tracing simpler as one 
does not have to remember each and every point on the three-class classification system. One 
just needs to score how many features fall into each of the categories and make an assessment. 
From a recent study by Ayres-de-Campos et al. comparing the FIGO guidelines, the 
RCOG/NICE guidelines, and the ACOG/NICHHD guidelines; it became clear that the lack of 
consensus in many aspects of universally accepted guidelines will remain a major limitation to 
the effectiveness ofCTG as a fetal monitoring technique.21 Further simplification ofthe existing 
guidelines and generalized assimilation of concepts and recommendations has been suggested as 
an important step to address this difficulty. 21 
1.7 The NICE guidelines for the use ofEFM 
In 2001 the National Institute of Health and Clinical Excellence (NICE) in the UK with the 
Department of Health developed clinical guidelines for the use of electronic fetal monitoring. 
They defined EFM as the use of electronic fetal heart rate monitoring for the evaluation of fetal 
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wellbeing in labour. The aim of these guidelines was to develop criteria for the use ofEFM, 
indications for use, definitions of normal and abnormal parameters, and to evaluate methods for 
improving interpretation of CTG. 1 
1.7.1 Interpretation of EFM according to the National Institute of Health and Clinical 
Excellence (NICE) guidelines 
Interpretation of EFM requires recognition of a normal pattern, and the results outside the normal 
range increase the probability of fetal compromise. 9 
Table 6 NICE Guidelines for definitions and descriptions of individual features of fetal 
heart rate traces1 
TERM 
Baseline fetal heart rate 
Normal Baseline FHR 
Moderate bradycardia 
Moderate tachycardia 
Abnormal bradycardia 
Abnormal tachycardia 
Baseline variability 
Normal baseline variability 
Non-reassuring baseline variability 
Abnormal baseline variability 
DESCRIPTION 
The mean level of the FHR when this is stable, 
excluding accelerations and decelerations. It is 
determined over a period of 5 or 10 minutes and 
expressed in beats per minute (bpm). Preterm foetuses 
tend to have values towards the upper end of this range. 
A trend to a progressive rise in the baseline is important 
as well as the absolute values. 
110-160pm 
100-109 bpm 
161-180bpm 
<100 bpm 
>180 bpm 
The minor fluctuations in baseline FHR occurring at 
three to five cycles per minute. It is measured by 
estimating the difference in beats per minute between 
the highest peak and lowest trough of fluctuation in a 
one-minute segment of the trace 
~ 5 bpm between contractions 
< 5 bpm for 2:40 minutes but < 90 minutes 
<5 bpm for ~90 minutes 
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Accelerations 
Decelerations 
Early decelerations 
Late decelerations 
Variable decelerations 
Atypical variable decelerations 
Prolonged deceleration 
Sinusoidal pattern 
Transient increases in FHR of~l5 bpm and lasting 
~15seconds. The significance of no accelerations on an 
otherwise normal CTG is unclear 
Transient episodes of slowing ofFHR below the 
baseline level of> 15 bpm and lasting ~15 seconds 
Uniform, repetitive, periodic slowing of FHR with onset 
early in the contraction and return to baseline at the end 
of the contraction 
Uniform, repetitive, periodic slowing of FHR with onset 
mid to end of the contraction and nadir >20 seconds 
after the peak of the contraction and ending after the 
contraction. In the presence of a non-accelerative trace 
with baseline variability < 5 bpm, the definition would 
include decelerations < 15 bpm 
Variable, intermittent periodic slowing ofFHR with 
rapid onset and recovery. Time relationships with 
contraction cycle are variable and they may occur in 
isolation. Sometimes they resemble other types of 
deceleration patterns in timing and shape 
Variable decelerations with any of the following 
additional components: 
i. Loss of primary or secondary rise in 
baseline rate, 
ii. Slow return to baseline FHR after the end 
ofthe contraction. 
iii. Prolonged secondary rise in baseline rate, 
IV. Biphasic deceleration, 
v. Loss of variability during deceleration, 
VI. Continuation of baseline rate at lower 
level. 
An abrupt decrease in FHR to levels below the baseline 
that lasts at least 60--90 seconds. These decelerations 
become pathological if they cross two contractions, i.e. 
>3 minutes 
A regular oscillation of the baseline long-term variability 
resembling a sine wave. This smooth, undulating 
pattern, lasting at least lOminutes, has a relatively fixed 
period of 3-5 cycles per minute and amplitude of 5-15 
bpm above and below the baseline. Baseline variability 
is absent. These ranges of baseline are not associated 
with hypoxia in the presence of accelerations, with 
normal baseline variability and no decelerations 
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Table 7. Classification of fetal heart rate features according to the NICE Guidelines1 
Feature Baseline rate (bpm) Variability Decelerations Acceleration 
Reassuring 110-160 ~5 None Present 
Non-reassuring 100- 109 <5 for >40 minutes Early decelerations The absence of 
but <90 minutes Variable accelerations with an 
161 -180 decelerations otherwise normal 
Single prolonged CTG is of uncertain 
deceleration < 3 significance. 
minutes 
Abnormal <100>180 < 5 for ~ 90 minutes Atypical variable 
Sinusoidal pattern decelerations 
for more than 10 Late decelerations 
minutes Single prolonged 
deceleration > 3 
minutes 
Table 8. Classification of CTG according to the NICE Guidelines1 
Category Definition 
Normal A CTG where all four features fall into the 'reassuring' category 
Suspicious A CTG where one of the features falls into 'non-reassuring' category 
and the remainder of the features is reassuring. 
Pathological A CTG whose features fall into two or more non-reassuring categories or one or more 
abnormal categories 
24 
Table 8 (above) helps to classify CTGs into one of the three groups where each group has a 
specific management plan. 
If a CTG is normal, then the fetus is healthy and there is no specific action required. 
In cases where the CTG is suspicious, intrapartum resuscitation should be instituted and CTG 
repeated. 
If the CTG is pathological, intrapartum resuscitation and fetal blood sampling should be 
performed. In situations where fetal blood sampling is contraindicated or not possible 
then delivery should be expedited by an assisted vaginal delivery if the cervix is fully dilated or 
caesarian section if not imminently deliverable.27 
When planning an intervention based on the changes on the CTG trace, the clinical picture as 
well as progress oflabour needs to be taken into consideration.2• 13•28 
The use of a standard, universal classification of the CTG is a necessity ?3• 27• 29• 30 It helps the 
clinicians to understand and effectively communicate issues relating to fetal wellbeing in one 
common language. It also helps the clinicians to appropriately institute interventions to prevent 
perinatal morbidity and mortality.29 
In South Africa there are no national or institutional guidelines for the interpretation of EFM 
traces. The result is that doctors do not know what to use especially in district hospitals where 
there are many inexperienced doctors. 
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1.8 Problem Statement 
The implementation of guidelines is intended to improve the efficacy ofEFM .The interpretation 
of the components of CTGs and NSTs vary from one clinician to the next, reducing the 
sensitivity of EFM. 
So far, the NICE guidelines for NST/CTG interpretation have not been evaluated; neither have 
they been compared to non-systematic assessments by eyeballing. The implementation of a 
scoring system that visually tabulates the NICE guidelines may improve the efficacy of EFM 
interpretation and reduce inter- and intra-observer variability and attempt to attain uniformity of 
interpretation. 
A tabular scoring system that uses the NICE guidelines to interpret CTGs has not been 
documented in the literature and hence the reason for this study. 
2. OBJECTIVES 
The objectives of this study are to: 
1) Assess consensus in the interpretation of CTGs and NSTs between different grades of 
obstetric clinical staffby comparing assessment of traces by non-systematic eyeballing 
with assessment of traces using a tabular approach suggested by the NICE guidelines for 
interpretation of CTGs and NSTs. 
2) Identify components ofNSTs and CTGs with which obstetric personnel experience 
difficulty with interpretation. 
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3. METHODS 
3.1 Setting 
This study was conducted at the Charlotte Maxeke Johannesburg Academic, Rahima Moosa and 
Chris Hani Baragwanath Academic hospital maternity units. These are tertiary care hospitals for 
the teaching and training of the Witwatersrand university postgraduates and are major referral 
centers for the Johannesburg region. These institutions also contribute to the training of 
midwives and interns. 
Registrars are continuously but informally trained on CTG interpretation through bedside 
teaching by consultants, tutorials, presentations and by attending perinatal morbidity and 
mortality meetings. Recently, a project by Johnson and Johnson in the Gauteng region has been 
dedicated to the formal training of midwives, interns and medical officers working in the 
maternity units on CTG interpretation. 
Currently, the above mentioned maternity units make use ofNSTs and CTGs for the evaluation 
of fetal wellbeing in high risk pregnancy and labour. NSTs and CTGs are performed in various 
wards by the nursing staff. The tracing is then presented to a doctor who interprets it and 
proposes further management of the patient. Fetal scalp blood sampling is not practiced due to 
the unknown rate of HIV seroconversion during pregnancy in the South African population, and 
because of practical difficulties with implementing fetal scalp blood sampling and analysis. 
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3.2 Study design and study population 
This is a prospective two part questionnaire study, conducted from April2010 to September 
2010. The study population was midwives, advanced midwives, interns, medical officers, 
registrars and specialists working in Chris Hani Baragwanath Academic, Charlotte Maxeke 
Johannesburg Academic and Rahima Moosa hospitals, being the personnel who assess EFM 
traces. A convenience sample of 100 such staff members was recruited from these institutions, 
according to their availability and willingness to participate in the study. 
3.3 Data Collection 
Participants were recruited at the time of formal gatherings and departmental meetings in the 
various institutions on days when the researcher was available. They were informed about the 
study and signed informed consent to participate. To avoid contamination of data, participants 
were requested not to communicate with each other about the study. 
3.3.1 The 2-part questionnaire 
Each participant completed two separate questionnaires that were kept anonymous by allocating 
study numbers. An attendance register of all the participants was made to prevent duplication of 
participation. 
3.3.2 First Questionnaire 
The first questionnaire included the rank of the participant and a total of five traces to interpret 
and assess using the following three global assessment categories, based on the management 
plan. 
1. Babywell 
2. Baby needs further surveillance 
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3. Baby needs immediate delivery 
The five traces were a combination ofCTGs and NSTs. These traces were labeled 1-5. In order 
to maintain uniformity, the same five traces were presented to all participants as scanned images. 
No clinical information was presented with the traces. 
First Questionnaire (see also appendix A) 
Please mark appropriate rank with X 
Rank X 
Midwife 
Advanced midwife 
Intern 
Community service 
Medical officer 
Registrar year 1 - 2 
Registrar year 3 - 4 
Senior medical officer 
Principal medical officer 
Specialist 
Please review each tracing and record your assessment according to one of the following 
assessments: 
1. Babywell 
2. Baby needs further surveillance 
3. Baby needs immediate delivery 
CTG/NST TRACE ASSESSMENT OF TRACE 
1 
2 
3 
4 
5 
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Feature 
3.3.3 Second Questionnaire 
A second questionnaire was issued to each participant immediately after collection of the first 
questionnaire. The second questionnaire included the same traces as the first, but an adapted 
tabular model of the NICE guidelines was provided for the participants to score the traces 
systematically (Table 9). The five traces were presented in a different sequence from those in the 
first questionnaire. Participants were asked to score the five traces separately for baseline, 
baseline variability, decelerations and accelerations. As shown on Table 9, they were then asked 
to interpret each of the tracings as normal, suspicious or pathological. 
Table 9 Tabular model of the NICE Guidelines with a scoring modification (see also 
appendix B) 
Mark appropriate box below with X Number of Assessment of trace 
parameters Ring appropriate 
marked number of features 
Baseline Variability Decelerations Accelerations with X marked with X (BPM) (BPM) 
Reassuring 110-160 ;:::5 None Present 4X Normal 
Non- 100-109 <5 for Early No lX Suspicious 
reassuring 161-180 40-90 decelerations. accelerations 
minutes Variable 
decelerations with 
>50% of ;:::2x Pathological 
contractions for > 
90 minutes. 
Single prolonged 
deceleration for < 
3 minutes. 
Abnormal <100 <5 for> 90 Atypical variable :=:tx Pathological 
>180. minutes decelerations with 
Sinusoidal >50%of 
pattern> contractions 
10 for>30 minutes. 
minutes Late decelerations 
for> 30 minutes. 
Single prolonged 
deceleration for > 
3 minutes. 
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Figure 1 Trace 1 
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Figure 2 Trace 2 
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Figure 3 Trace 3 
33 
----1-
Figure 4 Trace 4 
34 
Figure 5 Trace 5 
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3.4 Data analysis 
The study participants were categorized into three groups according to their rank where group 1 
constituted midwives, Group 2 -junior doctors (where junior doctors comprised interns, 
community service doctors, medical officers and registrars year 1 to year 2) and Group 3- senior 
doctors (registrars year 3 to year 4, senior medical officers, principal medical officers and 
specialists). 
The data was managed and analyzed using Stata 11 software. Descriptive statistics were 
employed by using means with standard deviations and medians with ranges. 
Frequencies were expressed in percentages with 95% confidence intervals. Differences in 
interpretation of each of the tracings by rank of health personnel (midwives, junior doctors, 
senior doctors) were assessed using Fisher's exact test. Statistical significance was assumed at a 
P-value less than 0.05. In order to determine the degree of certainty between study participants, a 
75% consensus among participants was used to determine certainty of the evaluation. If75% or 
more of the participants agreed on a category of evaluation then the evaluation by the study 
participants was considered to be certain. If consensus of participants was below 75% then there 
was uncertainty about the evaluation. 
3.5 Ethics 
The study was commenced after obtaining an ethical approval from the University of 
Witwatersrand Ethics Committee, M091136. 
Consent was obtained from each participant prior to inclusion in the study. In order to maintain 
anonymity, each participant was allocated a study number. The data sheet only reflected data 
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pertaining to the study and did not include the date, name or hospital of the participant. 
Participants retained the right to withdraw from the study at any time. 
The NSTs and CTGs did not reflect the patients' names or hospital numbers. 
4. RESULTS 
There was a total of 100 participants who were medical staff ranging from midwives to specialist 
obstetricians and gynecologists. Table 10 reflects the rank of the study participants. 
Table 10 Medical rank of participants and grouping into midwives, junior doctors and 
senior doctors 
RANK n n RANK GROUP 
Midwife 12 Midwives (Group 1) 15 
Advanced midwife 3 
Intern 10 Junior doctors (Group 2) 33 
Community service 4 
Medical officer 4 
Registrar year 1-2 15 
Registrar year 3-4 10 Senior doctors (Group 3) 50 
Senior medical officer 4 
Principal medical officer 9 
Specialist 27 
Blank 1 Excluded 2 
Incorrect 1 
Total 100 
The study participants were categorized into three groups as described earlier. There were 15 
study participants in group1, 33 in group 2 and 50 in group 3 (Table 10). 
The non-systematic assessment of the five traces by the participants not grouped by grade of 
staff is represented in Table 11. The nonsystematic evaluation was correctly completed by 98% 
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of participants for Traces 1 and 2. Ninety-seven percent of study participants correctly completed 
Traces 3, 4 and 5. The non-systematic assessment yielded varying interpretations by the various 
categories of medical staff. Interpretation ofTrace 3 gave the best agreement, with 77% of 
personnel stating that the baby needed immediate delivery. 
Table 11 Non systematic assessment of traces (n = 100) 
TRACE 1 TRACE2 TRACE3 TRACE4 TRACE 5 
Baby well 2 30 1 38 32 
Baby requires further surveillance 28 66 19 53 63 
Baby needs immediate delivery 68 2 77 6 2 
Blank 1 1 1 1 1 
Incorrectly completed 1 1 2 2 2 
Total 100 100 100 100 100 
Table 12 displays the interpretation of traces by the same participants using the tabular approach 
adapted from the NICE guidelines on electronic fetal monitoring. 
Good agreement on the description of the baseline was achieved in all five traces. Good 
agreement on the classification ofbaseline variability was seen in Traces 1, 4 and 5. The 
interpretation ofbaseline variability in Traces 2 and 3 varied, with the majority of participants 
describing the baseline variability as reassuring. The number of study participants who did not 
complete the baseline assessment ranged from 6% to 9% of the various traces. 
The interpretation of decelerations varied among the participants. There was good agreement in 
Traces 1 and 2 where 78% and 90% respectively agreed on the interpretation of decelerations. 
There was good agreement on the recognition of accelerations in Traces 2, 4 and 5. 
The overall assessment of the traces varied among the participants as to whether the traces were 
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normal, suspicious or pathological. Only in Trace 3 was there good agreement (84%). A large 
number of study participants did not complete the overall assessment of the trace, ranging from 
21% to 24% of the various traces, and up to 5% were incorrectly completed. 
Table 12 Systemic evaluation of traces using the NICE guidelines (n = 100) 
TRACE 1 TRACE2 TRACE3 TRACE4 TRACES 
BASELINE 
Reassuring 89(98) 93(100) 91(100) 82(90) 92(100) 
Non-reassuring 2(2) 0 0 7(8) 0 
Abnormal 0 0 0 2(2) 0 
Blank 9 6 8 8 7 
Incorrect 0 1 1 1 1 
BASELINE VARIABILITY 
ReassuriJ:!g 78(8'Q_ 60(66) 46(52) 8'!{92) 76(84) 
Non-reassuring 10(11) 29(32) 37(42) 6(7) 14(15) 
Abnormal ~2) 2(2) 5(6) 1(1) 1(1) 
Blank 10 9 12 9 9 
Incorrect 0 0 0 0 0 
DECELERATIONS 
Reassuring 0 81(90) 0 36(42) 56(64) 
Non-reassuring 70(78) 9(10) 42(4~ 42(48) 28(3~ 
Abnormal Atypical variable 13(14) 0 18(21) 7(8) 3(~ 
Late 4(4) 0 19(22)_ ~2J 0 
Single prolonged >3min 3(3) 0 7(8) 0 0 
Blank 7 10 6 10 12 
Incorrect 3 0 8 3 1 
ACCELERATIONS 
Reassuring(present) 54(63) 7(8) 31(35) 89(96) 12(14) 
Non-reassuring( absent) 31(37) 85(92) 57(65) 4(4) 76(86) 
Blank 12 8 9 7 10 
Incorrect 3 0 3 0 2 
ASSESSMENT 
Normal 0 7 0 36(46) 11(15) 
Suspicious 37(47) 49(69) 12(16) 36(46) 46(62) 
Pathological 41(53) 22(31) 62(84) 7(8) 17(23) 
Blank 19 21 21 21 24 
Incorrect 3 1 5 0 2 
*Calculated percentages m brackets excludmg those that were unknown. 
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Table 13 compares the non-systematic assessment of traces according to the grades of staff. 
There were statistically significant differences in the assessments of traces between the groups of 
participants in Traces 1, 2 and 4. 
In Trace 1, 28 of the junior doctors (85%) and 11 of the midwives (73%) suggested immediate 
delivery, while only 27 senior doctors (56%) made a similar suggestion (P = 0.005). 
In Trace 2 (Table 13) senior doctors showed certainty in suggesting further surveillance, 
compared with a much lower proportion of midwives and junior doctors (P = 0.033). 
There was a difference in the assessment of Trace 4 by senior doctors where the majority made a 
decision of"baby well", while the majority of junior doctors and midwives suggested further 
surveillance (P = 0.003). 
The systematic evaluation of Traces 1 to 5 (Table 14), by implementation of the tabular approach 
to the NICE guidelines, revealed no statistically significant differences in the interpretation of the 
baseline and the assessment of the traces. 
There was no statistically significant difference in the evaluation of each component (Baseline, 
Baseline variability, Decelerations, Accelerations, and Assessment) in Traces 2, 4 and 5 (Table 
14). 
A statistically significant difference in the evaluation of baseline variability was noted in Traces 
1 and 3 where in Trace 1 the midwife group was uncertain (Table 14). In Trace 3 there was a 
statistically significant difference noted in the evaluation that was made by study participants in 
the groups and there was uncertainty within each group (Table 14). 
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There was a statistically significant difference in the evaluation of accelerations in Trace 1 where 
the midwife group was certain about the evaluation and both groups of doctors were uncertain 
(Table 14). 
The evaluation of decelerations (Table 14) showed a statistically significant difference in Trace 3 
where certainty was not achieved by all groups with respect to the type of deceleration. Fifty 
three percent of midwives evaluated the decelerations as "late" whereas the majority of junior 
and senior doctors evaluated the decelerations as "non-reassuring". 
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Tab It' l3 Non-systematic assessment of traces accordinv, to the grades of staff (n = 96) 
C =CERTAIN (2: 75% agreement by participants on trace interpretation, shown as an asterisk*.) 
UC =UNCERTAIN(< 75% agreement by participants on trace interpretation.) 
' 
TRACEl TRACEZ TRACE3 TRACE4 TRACES 
P·VALUE P-VALUE P-VALUE P-VALUE P·VALUE 
Senior Senior Midwives Senior Midwives Senior Midwives Senior Midwives "Midwives Junior doctors 
doctors (n= 15) doctors (n= 14) doctors (n= 14) doctors (n= 14) doctors 
(n=IS) Junior (n=48) Junior (n=48) Junior (n =48) Junior (n=48) (n=33) (n=48) Doctors Doctors Doctors Doctors 
(n=33) (n=3) (n=33) (n =33) 
0.005 0.033 0.145 0.003 0.204 
1 1 0 7 13 9 0 1 0 3 7 28 8 8 14 
Baby Well 
3 4 21 7 20 38(79)• 2 3 13 10 23 19 6 24 33 
Baby requires 
further 
surveillanre 
. 
11 28(85)• 27 1 0 1 12(8W 29(88)0 35 1 3 1 0 1 1 
Baby needs 
immediate 
deliv~ry 
' 
uc c uc uc uc c c ' c uc uc uc uc uc uc uc 
Degree of 
certainty 
1.7 
Tahle 14 Systematic evaluation using NICE guidelines according to the grades of staff (n = 98) 
C =CERTAIN~ 75% agreement by participants on trace interpretation, shown as an asterisk*.) 
UC =UNCERTAIN(< 75% agreement by participants on trace interpretation) 
TRACE I TRACE2 
Midwives Junior Senior P~value Midwives Junior Senior P-valuc doctors doctors doctors doctors 
n=IS n=JJ n=SO n=IS n=JJ n=SO 
BASELINE 
Reassurin2 14' 27' 47' 14' 29' 48' 
Non-reassuring 0 0 I 0 0 0 
NS NS 
Abnormal 0 0 0 0 0 0 
Degree of certainty c c c c c c 
BASELINE VARIABILITY 
Reassuring 7 23' 47' 9 16 33 
Non-reassuring s 3 I 4 10 14 
<0.001 NS 
Abnormal I 0 0 0 I 0 
Degree of certai~ty uc c c uc uc uc 
DECELERATIONS 
Reassuring 0 0 0 12' 25' 43' 
Non-reassuril_!g _ II' 17 41' 2 I s 
Abnormal Atypical variable I 7 s 0 0 0 
I 3 NS 0 NS Abnormal-Late 0 0 0 
Single prolonged I 2 0 0 0 0 
>3minutes 
Degree of cenaintv c uc c c c c 
ACCELERATIONS 
Reassuring( present) 12' 18 24 3 0 4 
Non-reassuring( absent) I 8 22 0.02 12' 27' 44' NS 
Degree of certain~ c uc uc c c c 
ASSESSMENT 
Normal 0 0 0 2 0 s 
Suspicious 6 10 21 NS 6 14 29 NS 
Pathological 7 II 22 4 8 10 
Degree of certainty uc uc uc uc uc uc 
Midwives 
n=IS 
14' 
0 
0 
c 
3 
6 
3 
uc 
0 
4 
I 
8 
I 
uc 
3 
12' 
c 
0 
I 
II 
uc 
TRACEJ TRACE4 TRACES 
Junior Senior P-value Midwives Junior Senior P-value Midwives Junior Senior P-value doctors doctors doctors doctors doctors doctors 
n=JJ n=SO n=IS n=JJ n=SO n=IS n~JJ n=SO 
28' 48' 10 25' 46' 14' 28' 49' 
0 0 3 2 2 0 0 0 
NS NS NS 
0 0 I 0 I 0 0 0 
c c uc c c c c c 
20 21 8 25 48 II' 24' 40' 
7 23 3 2 I I 4 7 
0.006 NS NS 
I I I 0 0 I 0 0 
uc uc uc uc uc c c c 
0 0 s 9 22 4 19 33 
II 26 6 13 22 8 7 13 
6 10 I 3 3 I I I 
6 s 
0.037 
0 2 0 
NS 
0 0 0 
NS 
3 3 0 0 0 0 0 0 
uc uc uc uc uc uc uc uc 
12 16 IS' 26' 47' 3 4 s 
IS 28 NS 0 2 2 NS II' 22' 41' NS 
uc uc c c c c c c 
0 0 s 9 22 2 s 4 
3 8 NS 4 II 20 NS s II 30 NS 
18 33 3 3 I 3 6 8 
uc uc uc uc uc uc uc uc 
ft3 
5. DISCUSSION 
The primary objective of this study was to assess the uniformity of the observers at assessing 
NSTs and CTGs using the tabular approach from the NICE guidelines. Uniformity in the 
interpretation ofNSTs and CTGs may aid in the prediction of fetal outcomes. 
5.1 Medical rank of participants 
The study sample in Table 10 displays a good representation of the clinical practitioners in the 
maternity units including midwives, junior doctors and senior doctors. However, this was a 
convenience sample, and the staff who agreed to participate may not be representative of all staff 
in the obstetric departments. In the literature, there is no documentation on the comparison of the 
different grades of staff in an obstetric unit with respect to interpretation ofNSTs and CTGs. 
It is a known fact that formal education and training in EFM improves CTG interpretation. 
Randomized controlled trials have suggested that clinical experience and training in EFM and 
interpretation ofCTG traces improves knowledge and clinical skills.28•29It is, however, not 
known whether this has an impact on maternal and neonatal outcomes. In 2005 Blix et al. 
demonstrated that there was good agreement in the interpretation of 549 labour admission tests 
by midwives and obstetricians who had completed a training program in "fetal surveillance"?9 
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5.2 The non-systematic assessment of traces 
Table 11 shows considerable uncertainty in the non-systematic assessment of the traces with a 
statistically significant difference in the assessment of 3 of the traces between the groups as 
evidenced in Table 13. 
There is no uniformity in this assessment of traces and this is demonstrated by the fact that the 
degree of certainty varied among the staff grades. The non-systematic assessment of traces may 
incorporate a guideline approach for some individuals but also includes a component of 
experience which may have influenced the assessment. 
5.3 Systematic evaluation of traces using the NICE guidelines tabular model with a 
scoring modification 
5.3.1 Interpretation of fetal heart rate components 
The number of study participants who evaluated the traces by assessing the various components 
of a trace was reduced by the use of the tabular approach from the NICE guidelines. Table 11 
shows that 1% of the study participants did not complete the non-systemic assessment. When the 
fmdings of Table 11 are compared with Table 12 where 6%- 12% (Table 12) of study 
participants did not complete fetal heart rate components and 19% - 24% (Table 12) of the 
overall assessments were not completed. This may indicate that the participants were not familiar 
with the NICE guidelines approach or that they did not know how to apply information 
contained within the guidelines. It was also observed that some of the study participants 
evaluated each fetal heart rate component but were not able to assimilate the information into an 
overall assessment based on the contribution of the four features. 
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The findings revealed in Table 12 show that there was general agreement among participants on 
the classification of the baseline FHR. The study participants demonstrated uniformity in the 
assessment of baseline, which means that they found it uncomplicated to interpret. This fmding 
. . k . "th h . d. 2 8 17 18 19 A d C 1 d d d . IS m eepmg WI t e previOus stu Ies. ' ' ' ' yres- e- ampos et a . con ucte a stu y m 
2004 which demonstrated that the interpretation of fetal heart rate baseline is extremely 
reproducible. 28 A striking phenomenon in his study was the fact that agreement among the 
clinicians was higher if the clinicians were fully familiarized with the criteria used for 
classification and had prior training. 
The interpretation ofbaseline variability, decelerations and accelerations varied among the 
participants. The variation and uncertainty in the interpretation of baseline variability is in 
keeping with the previous studies as baseline variability was found to be the most difficult to 
interpret. The diversity in the evaluation of baseline variability, decelerations, the type of 
deceleration and accelerations demonstrates difficulty in the interpretation of these components. 
There has been inconsistency with the fmdings on the assessment of decelerations and 
accelerations in the literature. Difficulty in the evaluation of accelerations, decelerations and 
baseline variability in this study could be explained by: vague definitions in the assessment of 
fetal heart tracings; the nature of the FHR pattern (the more abnormal the FHR pattern the more 
difficult the interpretation); lack of experience and training on CTG analysis; short CTG tracings. 
This was, however, not measured in the study. 
Certainty in the recognition of accelerations was much better among the study participants when 
compared with the interpretation of decelerations and baseline variability. This may mean that 
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the study participants understand the definition of accelerations better than the other two CTG 
components. 
5.3.2 Classification of fetal heart rate patterns using the NICE guidelines 
The overall assessment of traces, using the NICE guidelines varied between the study 
participants. There is a statistically significant difference displayed among the rank groups in the 
non-systematic assessment ofthe traces as seen in Traces 1, 2 and 3 (Table 13). There is, 
however, no statistically significant difference noted among the groups in all the traces (Table 
14), when the NICE guidelines tabular approach is used to interpret NSTs and CTGs. Significant 
differences in interpretation of CTGs by the different grades of staff on non-systematic 
assessment disappeared when the tabular NICE definitions were applied. 
This means that the different rank groups interpret the traces more uniformly when using the 
NICE guidelines tabular approach, suggesting that staff grade-related differences in trace 
interpretations are reduced. However, there was still uncertainty in all the groups even with the 
NICE guidelines approach. 
5.3.3 Problem areas identified in the interpretation ofNSTs and CTGs 
The problem areas highlighted by this study are in the interpretation of the baseline variability, 
decelerations and the recognition of accelerations. A simpler system to define and interpret these 
fetal heart rate components, and a consensus regarding the management of specific patterns are 
needed. More work, by the maternity units, needs to be done to educate and train medical staff 
on CTG interpretation. The use of computerized CTG analysis may also assist with consistent 
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assessment of fetal heart rate patterns, but such modalities have not yet been fully evaluated in 
trials and meta-analysis. 
5.3.4 Limitations of this study 
1. The NST and CTG traces used in the study were short (20 minute traces). This makes the 
classification difficult especially for the interpretation of baseline variability which may 
need up to a 90-minute trace. 
2. Clinical information was not given to the observers with the NSTs and CTGs and this 
may add insight to the interpretation of a trace. The objectives of this study were not 
about the accuracy of CTG interpretation, it was about the consensus in the interpretation 
of CTGs among the different grades of obstetrics staff. 
3. The study did not evaluate the participant's prior education or level of training on CTG 
interpretation and it is known that the assessment of uniformity in CTG interpretation is 
influenced by experience or the level of training. 28' 29 Senior staff members are well 
trained on CTG interpretation but may not be familiar with the NICE guidelines approach 
as there is no standard protocol on which system to use for interpreting CTGs by these 
different institutions. 
4. The sample size may be too small. It may have shown no significant difference where 
there was in fact a difference (type 2 error), especially in the comparison of the NICE 
tabular approach. 
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6. CONCLUSION 
Some uniformity in the interpretation of CTGs and NSTs and reduction in inter-observer 
variation is attained by the use of the NICE guidelines tabular approach. 
There is a need for a standard, universal classification of CTGs. This has been addressed by 
many researchers as an intervention to try and minimize inter-observer variation in the 
interpretation of CTGs. The NICE guidelines tabular approach provides a system with a 
standardized terminology; a system that is simple to use, applicable to clinical practice, and 
reproducible. Education and training of the clinicians in maternity units on CTG interpretation is 
crucial. This would probably best be performed by individuals well versed in CTG interpretation 
as this study has also shown that there is a wide variation in interpretation which is also 
influenced by the clinical experience of the clinician. 
The application of the NICE guidelines may be better facilitated by using the tabular approach in 
the form of a stamp on each CTG or NST, where the clinician needs to classify each of the fetal 
heart rate features and then gives the overall assessment of the tracing. 
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APPENDIX A First questionnaire 
Please mark appropriate rank with X 
Rank X 
Midwife 
Advanced midwife 
Intern 
Community service 
Medical officer 
Registrar year 1 - 2 
Registrar year 3 - 4 
Senior medical officer 
Principal medical officer 
Specialist 
Please review each tracing and record your assessment according to one of the following 
assessments: 
1. Babywell 
2. Baby needs further surveillance 
3. Baby needs immediate delivery 
CTG/NST TRACE ASSESSMENT OF TRACE 
1 
2 
3 
4 
5 
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APPENDIX B Second questionnaire 
Feature Mark appropriate box below with X Number of Assessment of trace 
parameters 
Baseline Variability Decelerations Accelerations marked 
Ring appropriate 
(BPM) (BPM) with X 
number of Features 
marked with X 
Reassuring 110-160 2::5 None Present 4X Normal 
Non- 100-109 < 5 for2:: Early decelerations No 
reassuring 161-180 40mins Variable decelerations accelerations lX Suspicious 
but< 90 with> 50% of 
minutes contractions for 
> 90mins 
Single prolonged ~X Pathological 
deceleration for < 
3mins. 
Abnormal <100 <5 for2:: 90 Atypical variable 
>180 minutes decelerations with 
Sinusoidal >50% of contractions, 
pattem2:: > 30 minutes 
lOmins. 
Late decelerations, > ~lX Pathological 
30 minutes 
Single prolonged 
decelerations for > 3 
minutes 
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